diabetes - search results

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, explains how the COVID-19 pandemic is the scenario for testing and demonstrating the successful implementation of diabetes telehealth platforms.

Here, a leading clinical negligence specialist warns the UK may be heading for a “perfect storm” of diabetes complications, due to delayed COVID-19 referrals.

New research by the American Heart Association finds that obesity is a factor in almost half of all new cases, with obese individuals significantly more likely to get Type 2 diabetes.

In a new study, researchers will examine if changing our mealtimes to earlier or later in the day could reduce the risk of developing Type 2 diabetes.

According to a new study, pregnant women who exercise more during the first trimester may have a lower risk of developing gestational diabetes.

Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces ImotopesTM a cutting-edge immunotherapy science with an excellent safety profile that could cure Type 1 diabetes or drastically change treatment options.

Olivia is a registered nurse and public health practitioner passionate about improvement, involvement, and tackling inequalities. She is currently the Inpatient Care Lead at Diabetes UK.

Olivia Burr, Inpatient Care Lead at Diabetes UK, explains how COVID-19 has renewed momentum to improve inpatient diabetes care.

Claus Møldrup, DrugsDisclosed.com Founder and Former Professor in Social Pharmacy at the University of Copenhagen, turns the spotlight on diabetes and explores how to improve patient wellbeing and national health outcomes.

While diabetes has been declared as a signifier for infection complications, researchers now say that data suggests it is three times as likely these individuals have severe COVID or are hospitalised.

New research finds that bleeding and stroke are COVID-19 brain complications that are more frequent in people with diabetes and hypertension.

Dr Lucy Mackillop, Chief Medical Officer, Sensyne Health discusses the future of treating gestational diabetes.

Here the InBody Clinical Team explain how improved body composition can help fight type 2 diabetes.

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group considers how the standard of healthcare for patients with diabetes is impacted by COVID-19.

Researchers from the University of Seville have found that artificial intelligence (AI) can help to diagnose birth defects, gestational diabetes and preterm birth earlier.

After studying neuroscience at the University of Sussex, Lucy completed a PhD in behavioural nutrition followed by research positions at University College London and the University of Sussex. She maintains links with the University of Sussex as Honorary Senior Research Fellow. Lucy previously worked at the British Nutrition Foundation as...

Dr Lucy Chambers, Head of Research Communications at Diabetes UK, provides us with her thoughts on COVID-19 and diabetes, in terms of what do we (not) know.

Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces Imotopes™, the innovative new immunotherapy approach causing scientists to rethink Type 1 diabetes and its treatment.

Hjalte Hojsgaard, Insulet International, highlights why choice of insulin delivery devices is important, and why access to this life-changing technology is not yet fully utilised in UK diabetes services.

Digital health company Glooko sees a paradigm shift in healthcare with increased remote monitoring and easier access to telehealth.